Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products
WITHDRAWN  

Product information

Ranpirnase

EU orphan designation number: EU/3/01/033
Active ingredient: Ranpirnase
Indication: Treatment of malignant mesothelioma
Sponsor: MoRa Pharma GmbH
Alte Traubinger Str. 17, D-82340 Garatshausen am Starnberger See, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/03/2001 Centralised Orphan - Designation EMEA/OD/055/00 (2001)948 of 29/03/2001
06/03/2003 Centralised Orphan - Transfer of orphan designation EMEA/OD/055/00/T/01 (2003)676 of 04/03/2003
21/07/2008 Centralised Orphan - Change of address EMEA/OD/055/00
13/08/2010 Centralised Orphan - Removal of orphan designation from Community Register